Oxford BioMedica (GB:OXB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oxford Biomedica, a leading cell and gene therapy CDMO, has announced that Leone Patterson, a Non-Executive Director, will be resigning from Tenaya Therapeutics to take on a new role as Executive Vice President and Chief Business and Financial Officer at Zymeworks Inc. starting September 1, 2024. The company is known for its over 25 years of expertise in viral vectors essential for cell and gene therapies, and it partners with top biopharmaceutical firms to advance life-changing treatments.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.